What the study found
The review finds that the maternal microbiota, meaning the communities of microbes living in the body, is linked to pregnancy outcomes and early infant immune programming. It also describes how microbiota changes across pregnancy and early life are associated with pregnancy complications and later health risks.
Why the authors say this matters
The authors conclude that understanding how microbiota, hormones, and immunity interact provides a foundation for approaches intended to improve maternal and child health. They also note that this period may be important for shaping immune development and disease susceptibility.
What the researchers tested
This is a review article that synthesizes current findings on maternal–infant microbiome interactions. It covers evidence on microbial changes during gestation, possible microbial signals in the placenta and uterus, transfer of microbes during delivery and breastfeeding, and emerging microbiome-targeted therapies under investigation.
What worked and what didn't
The review states that microbial transfer through delivery, breastfeeding, and early environmental exposure is associated with seeding the neonatal gut with beneficial taxa such as Bifidobacterium and with immune tolerance mediated by factors including IgA, TGF-β, and human milk oligosaccharides. It also reports that cesarean delivery, antibiotic exposure, or maternal dysbiosis have been associated with higher risks of allergy, autoimmunity, obesity, and neurodevelopmental abnormalities later in life. Emerging therapies listed in the abstract include probiotics, prebiotics, fecal microbiota transplantation, next-generation microbial ecosystem therapeutics, and CRISPR-based approaches, but the abstract does not report their effectiveness.
What to keep in mind
The abstract says evidence for a true placental microbiome is still debated, and key gaps remain in understanding maternal immune–microbial signaling. It also notes that the long-term efficacy of microbiome-targeted therapies is not yet established.
Key points
- Maternal microbiota is linked to pregnancy outcomes and early infant immune programming.
- The review says the first 1,000 days are a critical window for gut microbiota establishment and immune development.
- Cesarean delivery, antibiotic exposure, and maternal dysbiosis are associated with higher risks of later health problems.
- Beneficial microbes such as Bifidobacterium may be transferred to infants through delivery, breastfeeding, and early-life exposures.
- The abstract says evidence for a placental microbiome remains debated.
Disclosure
- Research title:
- Maternal microbiome changes are linked to pregnancy and infant health
- Authors:
- Muhammad Junaid, Aftab Ahmad, Zeming Hu, Mengyao Xu, Xinyi Shi, Na Qu, Tianyu Du, Huiqing Ding, Yabin Zhu
- Institutions:
- Fourth Hospital of Hebei Medical University, Hebei Medical University, Ningbo First Hospital, Ningbo University, Ningbo University, Ningbo University, Ningbo University, Ningbo University, Ningbo University, Ningbo University, Ningbo University Affiliated Hospital
- Publication date:
- 2026-02-25
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with scholarly research without reading academic papers — one filtered digest, every Friday.